NCT01680640View on ClinicalTrials.gov

Investigation of Synbiotic Treatment in NAFLD

NACompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
DIETARY_SUPPLEMENT

Synbiotic

The synbiotic to be used is fructo-oligosacharide with a degree of polymerization \< 10 at 4 g/twice a day (two sticks a day) plus Bifidobacterium animalis subsp. lactis BB-12 as minimum of 10 billion CFU/day (1 capsule a day).

DIETARY_SUPPLEMENT

Maltodextrin

Trial Locations (1)

SO166YD

Southamption General Hospital, Southampton

All Listed Sponsors
collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

University Hospital Southampton NHS Foundation Trust

OTHER

NCT01680640 - Investigation of Synbiotic Treatment in NAFLD | Biotech Hunter | Biotech Hunter